Aethlon Medical, Inc.(NASDAQ : AEMD)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||-0.03%||485.95||1.0%||$1015.47m|
|ISRG||Intuitive Surgical, Inc.||-0.05%||884.54||2.3%||$471.64m|
|BDX||Becton, Dickinson & Co.||0.47%||241.39||1.0%||$357.28m|
|ALGN||Align Technology, Inc.||-0.75%||608.74||6.3%||$284.02m|
|BSX||Boston Scientific Corp.||-0.38%||43.19||1.0%||$269.07m|
|EW||Edwards Lifesciences Corp.||0.15%||101.14||0.4%||$236.68m|
|BAX||Baxter International, Inc.||-0.38%||80.85||1.8%||$220.46m|
|A||Agilent Technologies, Inc.||-0.76%||145.81||1.6%||$216.82m|
|ZBH||Zimmer Biomet Holdings, Inc.||-0.92%||158.91||1.7%||$198.34m|
|IDXX||IDEXX Laboratories, Inc.||-0.10%||603.62||3.8%||$195.80m|
Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.